I’m personally disappointed in how lackluster or outright bad RVNC’s share price has performed AFTER they got FDA approval. It’s not what I expected.
They had a fair amount of time to manufacture their product. If they knew they would need to train people in how to administer it, I am surprised they didn’t address the issue sooner.
I was surprised at the length of time they anticipate to ramp up sales.
I feel somewhat similarly. However, in the end the slow ramp up of sales doesn't matter. Well, it does if you use the time to buy a bit more RVNC at lower prices before sales ramp up.